World Pediatric Proton Therapy Market to Reach Over USD 700 Mln by 2021, Says Renub Research in Its New Study Available at MarketPublishers.com
28 Aug 2017 • by Natalie Aster
LONDON – The growing incidence rates of pediatric cancer has caused medical organisations to develop and implement sophisticated treatment procedures, which is termed proton radiotherapy. The efficacy of proton therapy keeps on gaining trust of pediatric cancer patients from pole to pole.
Worldwide, the childhood cancer rates are gaining fast-paced momentum. The global pediatric proton therapy market value is poised to surpass the USD 700 million mark by 2021. The USA takes the lead with respect to the number of proton therapy centers in the world due to its heavy investments in the creation of therapy centers along with its extensive history of proton beam therapy. Amid the five age groups discussed the (1-4) year grabs the largest market share in the USA. Meantime, the country will likely lose its big market share in the offing, on the back of tough competition from Germany, France, the UK and Japan.
The rising number of cancer diagnosed pediatric patients in Europe is set to enforce the many European countries to expand proton therapy centers on account of high demand. Technology advances are playing a very critical role in propelling the growth of the region’s pediatric proton therapy market. Germany is the largest market across Europe.
The Asian market has good potential due to the rising number of proton therapy centers in the region, especially in Japan, China and South Korea. Japan has already established their benchmark to treat pediatric patients using proton therapy. China primarily focuses on setting up 8 proton therapy centers to serve their huge population.
New report “Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated” created by Renub Research examines the market globally, focusing on the 10 major countries.
For the global and 10 national markets, the study analyses the current performance and potential growth of the pediatric proton therapy market; gives data on proton therapy patient numbers, actual and potential. The report provides an analysis of the 36 cancer type markets in the USA; analyses and forecasts the number of pediatric proton therapy patients by tumour type and age group in the USA. The report covers the technology types used in the current proton therapy centers, discusses the reimbursement policies for proton therapy across the world. An all-round analysis of the market driver and restraints is included. Furthermore, the research profiles the world’s 4 leading companies.
More new market research reports by Renub Research can be found at its page.